Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case study, a 10-year-old boy with alopecia caused by infections with Microsporum audouinii and Microsporum canis was successfully treated with oral griseofulvine over two months, highlighting a rare co-infection.

This study reported that administering lufenuron to dogs and cats effectively and rapidly resolved fungal infections within about 21 days for dogs and 12 days for cats, compared to around 90 days in untreated controls.

Terbinafine 250 mg is the most effective treatment for fungal nail infections.

This study identified new oxidative derivatives of finasteride, including a newly discovered metabolite, by using the fungus Macrophomina phaseolina.

This study developed a personalized microneedle that delivers finasteride directly to the skin, facilitating a sustained release and potentially reducing side effects associated with oral administration.

In this case report, a two-year-old girl with kerion type of tinea capitis successfully achieved clinical and mycologic cure with double pulse dose terbinafine and 2% ketoconazole shampoo over two months, with excellent tolerability and no side effects.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

This study found that Cinobufacin combined with chemotherapy improved clinical outcomes in breast cancer patients and reduced certain side effects compared to chemotherapy alone.

This case study documented a capuchin monkey with dermatophytosis caused by Microsporum canis, successfully treated with itraconazole, marking the first such report and treatment description for this species.

In this case study, an 11-year-old girl with a Cladosporium scalp infection showed significant improvement in hair growth and appearance after treatment with itraconazole.

In this study, secretomes from hypoxic mesenchymal stem cells were found to increase PDGF and reduce IL-1β gene expression in rats, potentially offering an effective topical treatment for alopecia caused by long-term fluconazole use.

This study reports that fluconazole emulgel formulations, using jojoba oil and liquid paraffin, showed effective drug release and improved characteristics for treating skin diseases compared to traditional oral formulations.

This case report describes a 2-year-old girl with Majocchi granuloma, a deep granulomatous folliculitis, which improved after treatment with oral terbinafine despite relapses leading to multiple treatment courses.

This study validated a UV-spectrophotometric method for accurately detecting Minoxidil and Tofacitinib citrate concentrations in bulk and gel formulations for alopecia areata, showing high recovery rates and indicating the method's suitability for routine analysis.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

This study presents a case of treatment-resistant alopecia universalis that successfully responded to a combination of tofacitinib and oral minoxidil, highlighting a potential therapeutic approach for challenging cases of alopecia areata.

This study reports a case of a Persian cat with Malassezia pachydermatis infection, treated with fluconazole, topical miconazole shampoo, and a skin tonic. The cat showed remarkable clinical improvement after one week and fully recovered after four weeks.

In this study, researchers developed a novel topical gel combining minoxidil and JAK inhibitor tofacitinib, which effectively enhanced hair follicle growth and reduced local inflammation in mice with alopecia areata, suggesting a new approach for treating this condition.

In this study, mozuku-derived ultra-high-molecular-weight fucoidan was found to inhibit the growth of skin bacteria like Staphylococcus aureus but not other tested bacteria such as Cutibacterium acnes.

This study found that a topical gel containing Minoxidil and Tofacitinib citrate showed promise for treating alopecia areata, with formulation F5 demonstrating effective drug release and stability in evaluations.

This review assessed trichoscopic findings in folliculotropic mycosis fungoides of the scalp, reporting features like milky-red globules and distinct vascular patterns, but noted the predominance of small studies and the need for larger research to validate trichoscopy's diagnostic utility for this condition.

The boy had a fungal scalp infection called kerion, which was cured with oral antifungal medication.

This report describes two cases of tinea capitis: one resistant to local iodine treatment after partial improvement, and another cured with the same treatment, in African American and Caucasian children, respectively.

This case report highlights a rare instance of CD8-positive hypopigmented mycosis fungoides causing alopecia areata-like changes, emphasizing the necessity of scalp biopsy in such presentations.

In this study, researchers observed that a topical gel containing 20% hypoxia mesenchymal stem cell secretome significantly reduced IL-15 and IFN-γ mRNA expression and baldness by 60% in male Wistar rats with fluconazole-related alopecia.

This case report highlights the successful treatment of degenerative mucinotic mural folliculitis in a 1.5-year-old indoor cat using high-dose ciclosporin, resulting in the resolution of alopecia and improved general condition over a 10-month period.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

This chapter reviews various fungal zoonoses, including dermatophytoses and trichophytosis, and reports no new empirical findings.

This review reports that tinea capitis is uncommon in adults, with postmenopausal African American or Black women at higher risk, and emphasizes the importance of prompt antifungal treatment to prevent complications.